Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection Resistant to Drugs”

196 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 196 results

Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Not applicableEnded earlyNCT01381757
What this trial is testing

Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali

Who this might be right for
Tuberculosis, PulmonaryMycobacterium TuberculousAntitubercular Agents+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 34
Not applicableStudy completedNCT02098616
What this trial is testing

Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus

Who this might be right for
Hepatitis C
Timothy Morgan, MD 25
Testing effectiveness (Phase 2)Study completedNCT04179500
What this trial is testing

A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+2 more
Global Alliance for TB Drug Development 26
Not applicableStudy completedNCT02605499
What this trial is testing

Ultra Violet-C Light Evaluation as an Adjunct to Removing Multi-Drug Resistant Organisms (UVCLEAR-MDRO)

Who this might be right for
Healthcare Associated InfectionMultidrug Resistant Organisms
Johns Hopkins University 83
Not applicableStudy completedNCT05306067
What this trial is testing

Plasmodium Falciparum Genomic Intelligence in Mozambique

Who this might be right for
Malaria,FalciparumMalaria in PregnancyMalaria
Centro de Investigacao em Saude de Manhica 21,848
Large-scale testing (Phase 3)Study completedNCT05349838
What this trial is testing

Open-Label Multi-Centre Randomised Switch Study to Evaluate Virological Efficacy Over 96Weeks Of 2-Drug Therapy With Dolutegravir(DTG)/Rilpivirine(RPV) Fixed Dose Combination(FDC) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTI Mutation K103N

Who this might be right for
HIV-1-infection
NEAT ID Foundation 140
Testing effectiveness (Phase 2)Study completedNCT00105157
What this trial is testing

Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED)

Who this might be right for
HIV InfectionsAcquired Immunodeficiency Syndrome
Merck Sharp & Dohme LLC 179
Not applicableUnknownNCT05300776
What this trial is testing

M-ROSE Combined With mNGS in Severe Hospital-acquired Pneumonia

Who this might be right for
Pneumonia
Chinese PLA General Hospital 166
Early research (Phase 1)Study completedNCT01856634
What this trial is testing

Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis

Who this might be right for
Multidrug Resistant TuberculosisPediatric
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Testing effectiveness (Phase 2)Looking for participantsNCT04759001
What this trial is testing

FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae

Who this might be right for
Enterobacteriaceae InfectionsMulti-antibiotic Resistance
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 52
Not applicableLooking for participantsNCT06738771
What this trial is testing

Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

Who this might be right for
Pseudomonas InfectionsPseudomonas AeruginosaPrognosis+3 more
Centre Hospitalier Régional d'Orléans 600
Post-approval studies (Phase 4)Study completedNCT03830671
What this trial is testing

The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB

Who this might be right for
Multi-drug Resistant Tuberculosis
Beijing Chest Hospital 515
Not applicableStudy completedNCT02736097
What this trial is testing

Drug Resistance Factors In Healthcare-associated Pneumonia

Who this might be right for
PneumoniaCritical Illness
Critical Care Pharmacotherapy Trials Network 679
Not applicableStudy completedNCT04928378
What this trial is testing

Bone Resistant Tuberculosis

Who this might be right for
Bone and Osteoarticular Infection Due to MDR M. Tuberculosis Strains
Assistance Publique - Hôpitaux de Paris 23
Not applicableActive Not RecruitingNCT05421286
What this trial is testing

The MISTRAL Study: Gut Microbiome Correlates of Serious AIDS and Non-AIDS Events

Who this might be right for
HIV-1-infectionInflammationAIDS
Rigshospitalet, Denmark 991
Large-scale testing (Phase 3)Study completedNCT02409290
What this trial is testing

The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB

Who this might be right for
MDR-TB
IUATLD, Inc 588
Large-scale testing (Phase 3)Study completedNCT03896685
What this trial is testing

Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)

Who this might be right for
Tuberculosis, Multidrug-ResistantTuberculosisPulmonary Tuberculoses+3 more
Médecins Sans Frontières, France 323
Large-scale testing (Phase 3)Ended earlyNCT00612898
What this trial is testing

Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection

Who this might be right for
HIV Infections
Avexa 239
Not applicableNot Yet RecruitingNCT05007795
What this trial is testing

Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis

Who this might be right for
Tuberculosis, Multidrug-Resistant
University of Cape Town 280
Load More Results